Authors: Abrey, LE Olson, JD Raizer, JJ Mack, M Rodavitch, A Boutros, DY Malkin, MG

Citation: Le. Abrey et al., A phase II trial of temozolomide for patients with recurrent or progressive brain metastases, J NEURO-ONC, 53(3), 2001, pp. 259-265

Authors: Muscat, JE Stellman, SD Malkin, MG Thompson, S Shore, RE Neugut, AI

Citation: Je. Muscat et al., Handheld cellular telephones and brain cancer risk - Reply, J AM MED A, 285(14), 2001, pp. 1838-1839

Authors: Vlassenko, AG Thiessen, B Beattie, BJ Malkin, MG Blasberg, RG

Citation: Ag. Vlassenko et al., Evaluation of early response to SU101 target-based therapy in patients with recurrent supratentorial malignant gliomas using FDG PET and Gd-DTPA MRI, J NEURO-ONC, 46(3), 2000, pp. 249-259

Authors: Kleber, MP Malkin, MG

Citation: Mp. Kleber et Mg. Malkin, Quality of life of adult survivors of germinomas treated with craniospinalirradiation - Comment, NEUROSURGER, 45(6), 1999, pp. 1297-1297

Authors: Buckner, JC Malkin, MG Reed, E Cascino, TL Reid, JM Ames, MM Tong, WPY Lim, S Figg, WD

Citation: Jc. Buckner et al., Phase II study of antineoplastons A10 (NSC 648539) and AS2-1 (NSC 620261) in patients with recurrent glioma, MAYO CLIN P, 74(2), 1999, pp. 137-145